An Italian Affair: the impact of Italy on the woman traveller in George Eliot’s Middlemarch and Henry James’s The Portrait of a Lady

The aim of this dissertation is to examine the impact of Italy on the woman traveller, primarily through an analysis of the ways they are presented in George Eliot’s Middlemarch and Henry James’s The Portrait of a Lady. The dissertation will examine the travel writings, journals and letters of George Eliot and Henry James in order to gain an insight into their own perceptions of the country. The travel writings of Victorian women travellers will also be discussed. The investigation is split into three chapters. The first chapter analyses the time spent by George Eliot and Henry James in Italy and their thoughts and experiences of the country and how this impacted on their novels. It will be discussed whether the style of their writing in their journals, letters and essays is different to their novels. The second chapter focuses mainly on the two heroines of the novels, Dorothea Brooke and Isabel Archer, and examines the effect that Italy had on them. This chapter will also look briefly at other women characters in The Portrait of a Lady, and in other novels and novellas by Henry James, and how Italy affected their lives and situations. The third chapter studies the travel writings of Victorian women who visited Italy. This chapter also reflects on how tourism to Italy enabled Victorian women to re-imagine their own reality at home. The conclusion will briefly discuss two novels by E. M. Forster to analyse how the depiction of the woman traveller to Italy had changed by the early twentieth century

Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.

Equine recurrent uveitis (ERU) is an immune-mediated disease causing repeated or persistent inflammatory episodes which can lead to blindness. Currently, there is no cure for horses with this disease. Mesenchymal stem cells (MSCs) are effective at reducing immune cell activation in vitro in many species, making them a potential therapeutic option for ERU. The objectives of this study were to define the lymphocyte phenotype of horses with ERU and to determine how MSCs alter T-cell phenotype in vitro. Whole blood was taken from 7 horses with ERU and 10 healthy horses and peripheral blood mononuclear cells were isolated. The markers CD21, CD3, CD4, and CD8 were used to identify lymphocyte subsets while CD25, CD62L, Foxp3, IFNγ, and IL10 were used to identify T-cell phenotype. Adipose-derived MSCs were expanded, irradiated (to control proliferation), and incubated with CD4+ T-cells from healthy horses, after which lymphocytes were collected and analyzed via flow cytometry. The percentages of T-cells and B-cells in horses with ERU were similar to normal horses. However, CD4+ T-cells from horses with ERU expressed higher amounts of IFNγ indicating a pro-inflammatory Th1 phenotype. When co-incubated with MSCs, activated CD4+ T-cells reduced expression of CD25, CD62L, Foxp3, and IFNγ. MSCs had a lesser ability to decrease activation when cell-cell contact or prostaglandin signaling was blocked. MSCs continue to show promise as a treatment for ERU as they decreased the CD4+ T-cell activation phenotype through a combination of cell-cell contact and prostaglandin signaling

Reply to Martens: Various factors may enable large populations to enhance cumulative cultural evolution, but more evidence is needed

Martens (1) suggests that including model-based bias (e.g., prestige) in our experiment would have enhanced cumulative cultural evolution (CCE) in the larger populations reported in our paper (2). This is a plausible hypothesis, but not one our experiment was designed to test. Given the controversy around the relationship between population size and CCE (3), our experiment was designed to isolate the basic effect of population size on CCE by excluding extraneous factors, including model-based bias. In our experiment increasing population size did not enhance CCE. We do not conclude that larger populations do not enhance CCE but that other factors may be necessary to see this benefit.Output Type: Lette

Increasing population size can inhibit cumulative cultural evolution

The extent to which larger populations enhance cumulative cultural evolution (CCE) is contentious. We report a large-scale experiment (n = 543) that investigates the CCE of technology (paper planes and their flight distances) using a transmission-chain design. Population size was manipulated such that participants could learn from the paper planes constructed by one, two, or four models from the prior generation. These social-learning conditions were compared with an asocial individual-learning condition in which individual participants made repeated attempts at constructing a paper plane, without having access to any planes produced by other participants. Larger populations generated greater variation in plane performance and gave participants access to better-adapted planes, but this did not enhance CCE. In fact, there was an inverse relationship between population size and CCE: plane flight distance did not improve over the experimental generations in the 2-Model and 4-Model conditions, but did improve over generations in the 1-Model social-learning condition. The incremental improvement in plane flight distance in the 1-Model social-learning condition was comparable to that in the Individual Learning condition, highlighting the importance of trial-and-error learning to artifact innovation and adaptation. An exploratory analysis indicated that the greater variation participants had access to in the larger populations may have overwhelmed their working memory and weakened their ability to selectively copy the best-adapted plane(s). We conclude that larger populations do not enhance artifact performance via CCE, and that it may be only under certain specific conditions that larger population sizes enhance CCE

Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses

Background. It is unknown whether horses that receive allogeneic mesenchymal stem cells (MSCs) injections develop specific humoral immune response. Our goal was to develop and validate a flow cytometric MSC crossmatch procedure and to determine if horses that received allogeneic MSCs in a clinical setting developed measurable antibodies following MSC administration. Methods. Serum was collected from a total of 19 horses enrolled in 3 different research projects. Horses in the 3 studies all received unmatched allogeneic MSCs. Bone marrow (BM) or adipose tissue derived MSCs (ad-MSCs) were administered via intravenous, intra-arterial, intratendon, or intraocular routes. Anti-MSCs and anti-bovine serum albumin antibodies were detected via flow cytometry and ELISA, respectively. Results. Overall, anti-MSC antibodies were detected in 37% of the horses. The majority of horses (89%) were positive for anti-bovine serum albumin (BSA) antibodies prior to and after MSC injection. Finally, there was no correlation between the amount of anti-BSA antibody and the development of anti-MSC antibodies. Conclusion. Anti allo-MSC antibody development was common; however, the significance of these antibodies is unknown. There was no correlation between either the presence or absence of antibodies and the percent antibody binding to MSCs and any adverse reaction to a MSC injection

A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis.

BackgroundThe ability of mesenchymal stem cells (MSCs) to modulate immune responses inspired a series of clinical trials addressing oral mucosal inflammation. We previously reported on the safety and efficacy of fresh, allogeneic and autologous, adipose-derived mesenchymal stem cells (ASCs) to treat feline gingivostomatitis (FCGS), an oral mucosal inflammatory disease that shares similarities with human oral lichen planus.MethodsTo meet clinical demand and goals for future commercialization, we determined the feasibility of shipping fresh ASCs to distant clinics and extended our pilot studies to expand safety and efficacy data for shipped and non-shipped ASCs in a cohort of 18 FCGS cats enrolled locally and at a few different locations within the USA.ResultsWe found that ASCs retained their viability, phenotype, and function after shipment. ASCs administered systemically resulted in a 72% positive response rate, identical to that noted in our previous studies. Cats that responded to ASC therapy had a significant decrease in circulating globulin concentration and histological evidence of decreased CD3+ T cells and CD20+ B cells in the oral mucosa. Responder cats also had significantly decreased percentages of CD8lo cells in blood prior to and at 3 months post-ASC therapy. CD8lo cells may serve as a potential "predictor" for response to systemic ASC therapy.ConclusionFresh feline ASCs can be successfully shipped and administered to cats with FCGS. ASCs modulate the immune response and demonstrate efficacy for chronic oral mucosal inflammatory lesions that are characterized by CD8+ T cell inflammation and T cell activation. FCGS is a potentially useful naturally occurring large animal model of human oral inflammatory diseases